Company
Novocure
NASDAQ:NVCR
Novocure is a private oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure’s US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Switzerland and Japan and a research center in Haifa, Israel.
5 stories
Chelsea FC deal is rare window on US hedge fund movers and shakers
Todd Boehly led the group, which includes private equity investment firm Clearlake Capital, Swiss billionaire Hansjörg Wyss and Guggenheim Partners chief executive Mark Walter
Archive
Energy stocks up after broker recommendations
Ur-Energy and Crius Energy Trust fare well on Thursday, but despite a thumbs up for Novocure the stock is down